431062-45-2

Basic information

• Product Name: methyl 2,3,5-tri-O-benzoyl-α-L-arabinofuranosyl-(1->6)-3,4-O-isopropylidene-α-D-galactopyranoside
• Synonyms: methyl 2,3,5-tri-O-benzoyl-α-L-arabinofuranosyl-(1->6)-3,4-O-isopropylidene-α-D-galactopyranoside
• CAS NO: 431062-45-2
• Molecular Weight: 678.69
• Mol File: 431062-45-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: methyl 2,3,5-tri-O-benzoyl-α-L-arabinofuranosyl-(1->6)-3,4-O-isopropylidene-α-D-galactopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2,3,5-tri-O-benzoyl-α-L-arabinofuranosyl-(1->6)-3,4-O-isopropylidene-α-D-galactopyranoside(431062-45-2)
• EPA Substance Registry System: methyl 2,3,5-tri-O-benzoyl-α-L-arabinofuranosyl-(1->6)-3,4-O-isopropylidene-α-D-galactopyranoside(431062-45-2)

Safety Data

• Hazardous Substances Data: 431062-45-2(Hazardous Substances Data)

Upstream product

• 40269-01-0 methyl 3,4-O-isopropylidene-α-D-galactopyranoside 
• 251451-05-5 2,3,5-tri-O-benzoyl-α-L-arabinofuranosyl 2,2,2-trichloroacetimidate 

Downstream Products

• 431062-48-5 methyl 2,3,5-tri-O-benzoyl-α-L-arabinofuranosyl-(1->6)-[2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl-(1->3)]-2-O-acetyl-α-D-galactopyranoside 
• 431062-60-1 methyl 2,3,5-tri-O-benzoyl-α-L-arabinofuranosyl-(1->6)-[2,6-di-O-benzoyl-β-D-galactopyranosyl-(1->3)]-2,4-di-O-acetyl-α-D-galactopyranoside 
• 431062-59-8 methyl 2,3,5-tri-O-benzoyl-α-L-arabinofuranosyl-(1->6)-[2,6-di-O-benzoyl-3,4-O-isopropylidene-β-D-galactopyranosyl-(1->3)]-2,4-di-O-acetyl-α-D-galactopyranoside 
• 431062-58-7 methyl 2,3,5-tri-O-benzoyl-α-L-arabinofuranosyl-(1->6)-[2,6-di-O-benzoyl-3,4-O-isopropylidene-β-D-galactopyranosyl-(1->3)]-2-O-acetyl-α-D-galactopyranoside 
• 431062-47-4 methyl 2,3,5-tri-O-benzoyl-α-L-arabinofuranosyl-(1->6)-2-O-acetyl-α-D-galactopyranoside 
• 431062-46-3 methyl 2,3,5-tri-O-benzoyl-α-L-arabinofuranosyl-(1->6)-2-O-acetyl-3,4-O-isopropylidene-α-D-galactopyranoside 

Relevant articles and documents

Synthesis of oligosaccharide derivatives related to those from sanqi, a Chinese herbal medicine from Panax notoginseng

Oligosaccharide derivatives from sanqi, a Chinese herbal medicine derived from Panax notoginseng, methyl β-D-galactopyranosyl-(1→3)-[α-L-arabinofuranosyl- (1→6)]-α-D-galactopyranoside, diosgenyl β-D-galactopyranosyl-(1→3)-[α-L-arabinofuranosyl- (1→6)]-α-D-galactopyranoside, and methyl β-D-galactopyranosyl-(1→3)-[α-L-arabinofuranosyl- (1→6)]-α-D-galactopyranosyl-(1→4)-β-D- galactopyranosyl-(1→3)-[α-L-arabinofuranosyl-(1→6)] -α-D-galactopyranoside, were synthesized under standard glycosylation conditions. An unexpected α-(1→4) linkage was formed predominantly in the presence of neighboring participation group during regioselective synthesis of hexasaccharide via 3+3 strategy.